Intraocular minocycline for the treatment of ocular pythiosis

Krajaejun, 2006, Clinical and epidemiological analyses of human pythiosis in Thailand, Clin Infect Dis, 43, 569, 10.1086/506353

Mendoza, 1993, Life cycle of the human and animal oomycete pathogen Pythium insidiosum, J Clin Microbiol, 31, 2967, 10.1128/JCM.31.11.2967-2973.1993

Lelievre, 2014, Imported Pythium insidiosum keratitis after a swim in Thailand by a contact lens-wearing traveler, Am J Trop Med Hyg, 92, 270, 10.4269/ajtmh.14-0380

Bell, 1999, Effects of methylprednisolone and cylosporine A on fungal growth in vitro, Cornea, 18, 306, 10.1097/00003226-199905000-00012

Pires, 2014, Photodynamic therapy in Pythium insidiosum—an in vitro study of the correlation of sensitizer localization and cell death, PLoS One, 9, e85431, 10.1371/journal.pone.0085431

Fiscella, 1996, Stability of cyclosporine 1% in artificial tears, J Ocul Pharmacol Ther, 12, 1, 10.1089/jop.1996.12.1

Seal, 1995, Chlorhexidine or polyhexamethylene biguanide for acanthamoeba keratitis, Lancet, 345, 136, 10.1016/S0140-6736(95)90106-X

Dupuis, 2009, Preparation and stability of voriconazole eye drop solution, Antimicrob Agents Chemother, 53, 798, 10.1128/AAC.01126-08

Morand, 2007, Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability, Int J Pharm, 344, 150, 10.1016/j.ijpharm.2007.04.028

Neoh, 2012, Stability of extemporaneously prepared 0.5-percent caspofungin eye drops: a potential cost-savings exercise, Antimicrob Agents Chemother, 56, 3435, 10.1128/AAC.00060-12

Lekhanont, 2009, Pythium insidiosum keratitis in contact lens wear: a case report, Cornea, 28, 1173, 10.1097/ICO.0b013e318199fa41

Hariprasad, 2008, Voriconazole in the treatment of fungal eye infections: a review of current literature, Br J Ophthalmol, 92, 871, 10.1136/bjo.2007.136515

Mittal, 2012, Intracameral and topical voriconazole for fungal corneal endoexudates, Cornea, 31, 366, 10.1097/ICO.0b013e318233f0a8

Yilmaz, 2007, Efficacy of intracameral amphotericin B injection in the management of refractory keratomycosis and endophthalmitis, Cornea, 26, 398, 10.1097/ICO.0b013e318030767e

Kaushik, 2001, Intracameral amphotericin B initial experience in severe keratomycosis, Cornea, 20, 715, 10.1097/00003226-200110000-00009

Carvalho, 2004, Liposomes as ocular drug delivery systems, Arch Soc Esp Oftalmol, 79, 151

Kaur, 2008, Development of effective ocular preparations of antifungal agents, J Ocul Pharmacologic Ther, 24, 481, 10.1089/jop.2008.0031

Short, 2008, Safety evaluation of ocular drug delivery formulations: techniques and practical considerations, Toxicol Pathol, 36, 49, 10.1177/0192623307310955

Kaji, 2009, Toxicities and pharmacokinetics of subconjunctival injection of liposomal amphotericin B, Graefes Arch Clin Exp Ophthalmol, 247, 549, 10.1007/s00417-008-1003-4

Tremblay, 1985, Reduced toxicity of liposome-associated amphotericin B injected intravitreally in rabbits, Invest Ophthalmol Vis Sci, 26, 711

Loreto, 2011, In vitro susceptibility of Pythium insidiosum to macrolides and tetracycline antibiotics, Antimicrob Agents Chemother, 55, 3588, 10.1128/AAC.01586-10

Gondola, 2013, A simple, rapid and inexpensive screening method for the identification of Pythium insidiosum, J Microbiol Methods, 93, 52, 10.1016/j.mimet.2013.02.002

Poirier, 1979, Ocular penetration of orally administered minocycline, Ann Ophthalmol, 11, 1859

Thanathanee, 2013, Outbreak of Pythium keratitis during rainy season: a case series, Cornea, 32, 199, 10.1097/ICO.0b013e3182535841

Imwidthaya, 1994, Human pythiosis in Thailand, Postgrad Med J, 70, 558, 10.1136/pgmj.70.826.558

Pereira, 2007, Caspofungin in vitro and in vivo activity against Brazilian Pythium insidiosum strains isolated from animals, J Antimicrob Chemother, 60, 1168, 10.1093/jac/dkm332

Horozoglu, 2012, Intravitreal tigecycline treatment in experimental Acinetobacter baumannii endophthalmitis, J Chemother, 24, 101, 10.1179/1120009X12Z.00000000018